quarterly activities report provides answers to a number of these - but I must admit - the "financing" of the company by the directors appears to be a show of faith.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
